In its accelerated approval decisions of new cancer drugs, the FDA might be underestimating the willingness of some patients to wait for greater certainty of survival benefit,” researchers wrote.

Topline results were announced from a phase 3 trial evaluating linerixibat for the treatment of cholestatic pruritus in patients with primary biliary cholangitis (PBC).

The USPSTF concludes with high certainty that screening asymptomatic pregnant persons for syphilis infection has a substantial net benefit. (HealthDay News) — The US Preventive Services Task Force ...

Since 2017 to 2018 season, there has been a decrease in the proportion of hospitalized children receiving antiviral treatment ...

Flare-free, treatment-free complete remission and flare-free, glucocorticoid-free complete remission improved with inebilizumab ...

The Food and Drug Administration (FDA) has approved Bimzelx ® (bimekizumab-bkzx) for the treatment of moderate to severe hidradenitis suppurativa (HS) in adults.

Credit: Endo, Inc At this time, there have been no reports of adverse events related to this recall. While the blister strips ...

The First to Know Syphilis Test retails for $29.99 and is available online and at major retailers and pharmacies.

Icotrokinra, formerly known as JNJ-2113, is an investigational oral peptide that blocks the interleukin (IL)-23 receptor, which plays a significant role in the pathogenesis of moderate to severe ...

The phase 3 trial met both primary pharmacokinetic endpoints. Topline results were announced from a phase 3 trial investigating a subcutaneous formulation of pembrolizumab, a programmed death receptor ...

From 2022 to 2023, there was a 20 percent increase in estimated measles cases worldwide, from 8,645,000 to 10,341,000 ...

“The results of this cohort study suggest that metformin was associated with a lower rate of asthma attacks, with further reductions with the use of GLP-1 RA,” the authors write. “This appeared to be ...